Nemaura Medical, Inc. · OTC:NMRD
Nemaura Medical — Corporate Update (August 2020)
12 slides from Nemaura Medical's corporate update, Aug 19, 2020
Slide 1: Better Diagnostics for Life: Continuous Glucose Monitoring in Hospitalised and Quarantined Patients with COVID-19
Better Diagnostics for Life Continuous Glucose Monitoring in Hospitalised and Quarantined Patients with COVID - 19 August 2020
Slide 2: Special Note Regarding Forward-Looking Statements
2 SPECIAL NOTE REGARDING FORWARD - LOOKING STATEMENTS • • This presentation may contain forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as ame nded, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that are subject
Slide 3: Authors
3 Authors • Dr Moiz Khan, Pharm.D , MBA • Stephen Willmor, BSc
Slide 4: Overview
4 Overview This presentation highlights the potential applications and benefits of Continuous Glucose Monitoring (CGM) in monitoring disease progression and improving outcomes in patients infected with COVID - 19. The following areas have been looked at: - Recent reports of the effect of monitoring
Slide 5: Multi-centred study of 7,337 COVID-19 cases in Hubei Province, China
5 Multi - centred study of 7,337 cases of COVID - 19 in Hubei Province, China, among which 952 had pre - existing T2D 1
Slide 6: Multi-centred study of 7,337 COVID-19 cases: summary and conclusion
6 Multi - centred study of 7,337 cases of COVID - 19 in Hubei Province, China, among which 952 had pre - existing T2D Summary: • Patients with T2D required more medical interventions and had a significantly higher mortality (7.8% versus 2.7%) and multiple organ injury than the non - diabetic individ
Slide 7: Chinese CDC: largest case series to date of COVID-19
7 The Chinese Centre for Disease Control and Prevention: largest case series to date of COVID - 19 2 Summary • The Chinese Centre for Disease Control and Prevention published the largest case series to date of coronavirus disease 2019 (COVID - 19) in mainland China (72,314 cases) . • The case fatali
Slide 8: Blood glucose monitoring crucial for quarantined COVID-19 patients
8 Blood glucose monitoring are crucial for quarantined COVID - 19 patients 3 Summary: • Patients critically ill with COVID - 19 often have compromised lung function which can result in reduced oxygen levels and hypoxia. • COVID - 19 patients are likely to develop hyperglycaemia under such a persiste
Slide 9: Sheba Medical Centre - Government Hospital in Israel
9 Sheba Medical Centre - Government Hospital in Israel 4 Summary: • The care of diabetic patients with COVID - 19 in isolation presents a challenge in terms of staff exposure to potential infection. • To prevent patient - staff transmission, monitoring of glucose levels remotel y from outside the de
Slide 10: Emerging Considerations for Remote Glucose Monitoring during the COVID-19 Pandemic
10 Emerging Considerations for Remote Glucose Monitoring during the COVID - 19 Pandemic 5 Summary: • Changes in hospital patient care have been made to address critical supply shortages, most notably the lack of personal protective equipment (PPE) available to healthcare workers (HCW). • The traditi
Slide 11: Overall Conclusions
11 Overall Conclusions • CGM can be used as part of a system to monitor disease progression in patients with COVID - 19. • People with diabetes are more prone to developing critical condition / dying after infection with COVID - 19 than general population so monitoring blood glucose levels to contro
Slide 12: References
12 References 1 Association of Blood Glucose Control and Outcomes in Patients with COVID - 19 and Pre - existing Type 2 Diabetes ( https://www.sciencedirect.com/science/article/pii/S1550413120302382 ) 2 Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID - 19) Outbreak